Psychological and behavioral therapies are being increasingly used for symptom management in patients with irritable bowel syndrome (IBS). The aims of this study were to compare two delivery modes for a comprehensive self-management (CSM) intervention, primarily by telephone vs. entirely in person, and to compare each with usual care (UC).
INTRODUCTION
Th ere is increasing evidence that psychological treatments, including cognitive behavioral therapy (CBT), are eff ective strategies for the management of patients with irritable bowel syndrome (IBS) (1) . Th e use of CBT is based on the hypothesis that IBS symptoms are due, at least in part, to dysfunctional cognitions regarding visceral sensations (2, 3) . CBT has been compared with standard medical care using both an individual presentation (4, 5) and small groups (6) . When compared with education alone, CBT was shown to decrease gastrointestinal (GI) symptoms to a greater extent (7) . In a study using group therapy, the psychoeducation support group was as eff ective as the cognitive therapy group in reducing GI symptoms, and both were more eff ective than daily stress monitoring (6) . In Great Britain, a nurse-delivered CBT plus mebeverine intervention when compared with mebeverine alone was found to produce greater reductions in symptom severity, with the response being sustained for 12 months (8) .
In an earlier study, our team combined CBT with education, relaxation training, and diet management into an eight-session comprehensive self-management (CSM) program for patients with IBS (5) . When compared with usual care (UC), this full eight-session CSM delivered by an advanced practice nurse resulted in improvements in GI symptoms and quality of life (QOL) that were sustained at 12 months post intervention (5) . One problem noted in this study was that the need for weekly travel to the intervention site imposed a burden on patients.
Alternatives to face-to-face approaches for the eff ective delivery of therapist-intensive interventions are prompted by concerns over travel time, clinical availability, and disruptions in patients ' daily activities. Telephone, web-based, and video conferencing may all yield benefi ts in terms of access and convenience (9, 10) . Previous research has shown the feasibility of using the telephone to deliver interventions for depression (11 -14) and anxiety disorders (9, 15) , as well as in cancersymptom management (16, 17) and smoking cessation (18, 19) . In most cases, cognitive behavioral interventions delivered by telephone or by a combination of telephone and in-person sessions were as eff ective as those relying exclusively on in-person groups (15) , and were more eff ective than UC (13, 17, 20) , attention control (14) , or care management approach (12) . However, in one study, cancer-symptom management by telephone did not diff er from UC (16) .
Th e goal of this study was to modify the previously tested CSM intervention for delivery by telephone, and compare the effi cacy of CSM delivered mainly by telephone (CSM-T / IP) with in-person delivery (CSM-IP) and usual care. We hypothesized that those in the CSM-IP and CSM-T / IP groups would demonstrate decreased GI symptoms and enhanced QOL compared with those in the UC group, and that outcomes in the CSM-T / IP group would be comparable with those in the CSM-IP group.
METHODS
A three-arm randomized controlled trial design (CSM-IP, CSM-T / IP, and UC) was used with a 12-month longitudinal follow-up. All the three groups completed interviews and questionnaires, and maintained a symptom diary for primary and secondary outcomes at each of the four assessment periods (namely baseline, 3, 6 , and 12 months post randomization).
Recruitment and eligibility
Recruitment . Volunteers with IBS were recruited through community advertisements and a single mailing to patients in a university-based gastroenterology practice.
Study eligibility . To be included, men and women had to be at least 18 years of age, had to have a previous diagnosis of IBS made by a health-care provider, and had to report current IBS symptoms (Rome-II criteria). Participants were excluded if they had a history of coexisting GI pathology (e.g., infl ammatory bowel disease, celiac disease) or surgery (e.g., bowel resection), or renal or reproductive pathology (e.g., endometriosis, prostate cancer). Participants with certain other comorbidities or medication use were also excluded on the basis of the guiding principle of whether the disorder or medications could confound the measurement of IBS symptoms or compromise the subject ' s ability to complete the study. Subjects were excluded for conditions such as severe fi bromyalgia, type I or II diabetes mellitus, infectious diseases (e.g., hepatitis B or C, human immunodefi ciency virus), symptoms of dementia, untreated sleep apnea / hypopnea, severe cardiovascular disease, severe depression, and current substance abuse. Examples of medications that lead to exclusion included the regular use of antibiotics, anticholinergics, cholestyramine, narcotics, colchicine, docusate, enema preparations, iron supplements, or laxatives. Human subjects institutional review approval was obtained before enrolling participants (May 2002) and was renewed yearly thereaft er. Th is study was registered with http:// clinicaltrials.gov through the US National Institutes of Health.
Baseline assessment
Baseline assessment was a six-step process over 6 to 9 weeks. In step 1, subjects were assessed for eligibility at an initial telephone screening.
Step 2 was an in-person session in which written consent was obtained, a health interview was conducted by a research nurse, and questionnaires were completed.
Step 3 was the assessment of a 4-week symptom diary completed each evening to determine whether the subjects had both abdominal pain / discomfort and diarrhea or constipation at least 25 % of the days.
Step 4 was a computerized mental health assessment carried out over the telephone sometime during the 4 weeks of the diary. Th e fi ft h step was a review by a gastroenterologist of all baseline data to determine whether the diagnosis of IBS was appropriate and there were no red fl ags that indicated a need for further assessment. Finally, subjects who were eligible to be randomized were asked whether they wished to continue with the study.
Randomization
Subjects were randomized to one of the three treatment arms. A computerized adaptive randomization procedure (21) was used to ensure that all the three groups remained balanced with respect to age, sex, predominant stool consistency (loose stools, hard stools), and severity of abdominal pain (mild vs. moderate to severe) at baseline. Randomization started in April 2003 and ended in January 2007.
Treatment phase
Th e intervention was delivered in nine individual 1-h sessions by two research nurses who were trained as psychiatric nurse practitioners. Owing to potential unexpected delays, we allowed up to 13 weeks to complete the nine sessions. Participants in the individualized CSM-IP group were seen at the study research offi ce for all the nine sessions. Th ose in the CSM-T / IP group had their fi rst two sessions in the study offi ce to build rapport and teach breathing exercises. Sessions 3 through 8 were conducted over telephone, and the last session FUNCTIONAL GI DISORDERS Jarrett et al.
(termination) was at the study research offi ce. An IBS Workbook was used so that the participants could read the content for the week before commencement of the session.
CSM-IP and CSM-T / IP protocol . Th e intervention received by the CSM-IP and CSM-T / IP groups covered the following four themes: education, diet, relaxation, and cognitive-behavioral strategies ( Table 1 ). Initially, IBS was defi ned for participants and reassurance was given that IBS is not life threatening. Signs and symptoms that required consulting a health-care provider were reviewed. Th e participants completed a food frequency questionnaire (22, 23) that was reviewed by a registered dietician to identify problems in the diet. Th is information was used to tailor instructions on healthy eating strategies. Th e participants were taught to recognize foods that were associated with their symptoms (e.g., coff ee, fatty foods, raw vegetables), as well as situations in which select foods were not tolerated (e.g., a time of high work stress) (24, 25) . Homework included maintaining a food diary to identify when they ate, what they ate, and what was happening in their environment. Relaxation training included abdominal breathing, progressive muscle relaxation (26) , and mini relaxations (27) . Homework included abdominal breathing at least thrice a day (e.g., before each meal), use of relaxation audio recordings thrice a week, and daily mini relaxation using tension as a cue. Specifi c cognitive behavioral strategies were selected on the basis of individualized assessment. Th ese included examining alternative thinking, cognitive distortions, assertiveness and social skills training, and social support. Homework included writing down their automatic thoughts and identifying and using alternative thoughts (28, 29) . Aft er each session, the research nurse recorded the percentage of homework completed in the session notes.
UC protocol . Participants in the UC group were notifi ed that they would not receive either of the active intervention, but should continue with whatever treatment was recommended or provided by their health-care provider. Th ey were informed that they would be contacted in 2 months for the fi rst of the follow-up visits. At the end of the study, they were sent the study workbook.
Follow-up phase
Participants in all the three groups were reassessed for primary and secondary outcomes (questionnaires and 4-week diary) at 3, 6, and 12 months post randomization. Th e 3-month followup was designed to be shortly aft er the last treatment session. Follow-up data collection was carried out by a research nurse who was blinded to the group assignment.
Measures
Primary outcomes . IBS symptom score : Everyday, subjects rated 26 symptoms on a scale of 0 (not present), 1 (mild), 2 (moderate), 3 (severe), or 4 (very severe). Of these, six were GI symptoms related to IBS: abdominal pain or discomfort, bloating, constipation, diarrhea, intestinal gas, and urgency. An IBS symptom score was computed by fi rst determining the severity of the worst IBS symptom on each day to get an IBS severity for that day, then collapsing across the diary days for each subject to determine the percentage of days with moderate-to-verysevere GI symptoms (30, 31) .
Quality of life : Th e IBS-QOL questionnaire is a 42-item questionnaire with nine scales: sleep, emotional, mental health beliefs, energy, physical functioning, diet, social role, physical role, and sexual relations (32) . Example questions are " How oft en did your IBS make you feel fed up or frustrated " e.g., 1 (always), 2 (oft en), 3 (sometimes), 4 (seldom), or 5 (never); or " My IBS aff ected my ability to succeed at work / main activity " e.g., 1 (strongly agree) to 5 (strongly disagree). Th e scales were transformed to a standard 0 to 100 scale. A total score was computed by averaging all but two of the scales (eating / diet and sexual relations). Th e eating / diet scale was omitted because participants in the CSM groups were encouraged to avoid foods that caused problems for them. Th e sexual relations scale was omitted because it was missing for a large fraction of the sample had not been sexually active in the previous 4 weeks. Extensive and acceptable validity and reliability tests have been conducted (32) . Internal consistency (Cronbach ' s alpha) for the scales ranged from α = 0.73 to α = 0.93 for this study.
Secondary outcomes . Psychological distress : Th e BSI (Brief Symptoms Index) includes 53 symptoms that are grouped into nine subscales: depression, hostility, somatization, interpersonal sensitivity, psychoticism, obsessive-compulsive, anxiety, phobic anxiety, paranoid ideation, and a mean score of all items (Global Severity Index). Th e subject was asked to consider the 
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Comprehensive Self-Management for Adults With IBS last 7 days, and then rate each symptom as distressing on a scale of 0 (not at all) to 4 (extremely). However, for follow-up assessments, BSI-18 was used, which includes three subscales, namely anxiety, depression, and somatization. Th is BSI is based on Symptom Checklist-90-Revised (SCL-90-R), which has been normalized on men and women and adolescents in non-patient and adult psychiatric outpatient and in-patient samples. Internal consistency of the subscale scores is reported to range from α = 0.77 to α = 0.90 and the test -retest reliability (1-week interval) was 0.78 to 0.90 (33) . For this study, the internal consistency was α = 0.88 for the Global Severity Index, α = 0.80 for Anxiety, α = 0.85 for Depression, and α = 0.69 for Somatization at Baseline.
Cognitive beliefs : Th e CSFBD (Cognitive Scale for Functional Bowel Disorders) describes 25 cognitive beliefs related to functional bowel disorders (34) . Th e items are rated from 1 (strongly disagree) to 7 (strongly agree). A typical item is, " I oft en worry that there might not be a bathroom available when I need it. " Th e CSFBD has high concurrent criterion validity, acceptable convergent validity, and high content validity and face validity, with minimal social desirability contamination (34) . Th e internal consistency for this study was α = 0.937. Th e summary score was the mean of all items.
Work productivity and activity : Th e WPAI (Work Productivity and Activity Impairment Questionnaire) has been adapted for individuals with IBS (35) . It includes nine questions related to the impact of IBS on work and other regular activities. Construct validity is acceptable when tested against known measures in employed individuals aff ected by a health problem. Th e test -retest (1 day) ranged from r = 0.71 to r = 0.95 for the items (35) . For this analysis, two scales are used: the Overall Work Productivity Loss (missed work and work impairment due to IBS) and the Daily Activity Impairment scales (impairment while working due to IBS).
Quality control, blinding, and safety measures : Quality control and safety measures included the use of a standardized protocol manual and standardized training. Th e two advanced practice nurses who delivered the intervention were aware of the group assignment and provided both interventions. A third nurse collected follow-up data and was blinded to the participant ' s group assignment. Weekly staff meetings were held to review study implementation. CSM sessions were audio recorded to assess adherence to the intervention protocol. Th ree randomly selected recordings per participant were reviewed using a checklist for compliance with the protocol. Our Data Safety Monitoring Board met before the start of the study and yearly thereaft er, until the study was completed.
Sample size determination
Th e goal of the study was to assess 180 subjects with analyzable follow-up data. With that sample size, there would be 81 % power if the change in QOL or IBS symptom score was 0.5 s.d. higher in the two CSMs than in the UC group, or 93 % power if the change in QOL or IBS symptom score was 0.6 s.d. higher. Th ese power calculations are based on ANOVA (analysis of variance) at one time point, but actual analyses use data from three time points and control for baseline, hence power is somewhat higher. Our earlier study showed a diff erence of ~ 0.7 s.d. between CSM and UC.
Analysis
Th e two primary outcome variables (IBS symptom score and QOL) were analyzed separately. For each, data from the three follow-up time points were analyzed together, using a mixed model, with subject as a random eff ect and treatment group (three levels, CSM-IP, CSM-T / IP, UC) and measurement time (three levels, 3, 6, 12 months) as fi xed factors. Th e analyses controlled for covariates that might be related to outcomes, such as baseline levels of the outcome variable as well as QOL and psychological distress at baseline. Th e main eff ect for the group was used to test whether the three treatment groups differed with respect to GI symptoms at follow-up. Whenever this overall main eff ect was signifi cant, univariate ANOVAs were carried out at each follow-up time point and appropriate contrasts were used to test all pairwise comparisons (CSM-T / IP vs. UC, CSM-IP vs. Usual Care, and CSM-T / IP vs. CSM-IP). Similar analyses were carried out for secondary outcomes.
Two binary symptom improvement variables were created, defi ned as a 50 % decrease from baseline in the IBS symptom score ( % of days with at least moderate symptom) and a 50 % decrease in the abdominal pain / discomfort score. Logistic regression was used to estimate the odds ratios for probability of improvement in each CSM group relative to UC, controlling for baseline. Th ese analyses will allow a comparison of our results with those reported in two recent meta-analyses (1, 36) , which reviewed a number of studies using psychological interventions for IBS, wherein a 50 % improvement in symptoms was used as the primary outcome. Some pain researchers would regard a 50 % criterion as being excessively stringent and prefer a 30 % threshold for clinical signifi cance (37) ; however, the 50 % threshold is what has been reported in IBS literature.
An intent-to-treat approach was used in this study. Th at is, every eff ort was made to collect follow-up data on every subject who was randomized, regardless of how many intervention sessions were attended, and all subjects on whom follow-up data were available were included in the analysis. Table 2 is the consolidated standards of reporting trials (CONSORT) diagram showing numbers of subjects screened, randomized, and followed up. A total of 188 subjects were randomized and only 12 of them (6 % ) failed to provide any followup data. In all, 87 % of subjects assigned to CSM received at least seven out of nine sessions. Homework was assigned between treatment sessions and 90 % of CSM-T / IP subjects and 91 % of CSM-IP subjects met our expectations for homework completion, i.e., at least 75 % of assigned work was completed during at least 75 % of the sessions.
RESULTS

Participant fl ow and follow-up
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symptoms started at 50 years or more. Half of the subjects were diagnosed by a gastroenterologist and the rest by a primary care provider (i.e., family practice physician, internist, nurse practitioner, physician ' s assistant, or other). Th e average age of fi rst IBS diagnosis was 27 years (s.d. 14). Neither demographic nor IBS characteristics diff ered statistically among groups. In all, 12 participants in this study did not provide any follow-up data. Th e participants who had no follow-up data (6 % ) or partial follow-up data (13 % ) did not diff er on demographic variables or IBS characteristics from those who had complete data (86 % ). Table 4 shows the baseline means and change scores of primary and secondary outcome variables in the three treatment groups. Th e two CSM groups show a large improvement from baseline to 3 months in primary outcomes that persisted at 6 and 12 months. It is noteworthy that for the QOL, an increase indicates improvement, whereas for the other variables, a decrease (minus value) indicates improvement. Th ere was no signifi cant diff erence in the amount of improvement in CSM-T / IP compared with that in CSM-IP. Figures 1 and 2 further illustrate these results for the two primary outcome variables.
Primary and secondary outcomes
Results are similar for most secondary outcomes, with both CSM groups being better than UC, and the CSM groups not diff ering from each other. However, for psychological distress, there is a trend toward better outcomes in CSM-T / IP than in CSM-IP, whereas for CSFBD, there is a trend toward better outcomes in CSM-IP than in CSM-T / IP. It is also noteworthy that the treatment diff erences for psychological distress are due to the worsening of symptoms in the UC group more than the improvement in the intervention groups. Th e intervention eff ect was stronger for the WPAI measure of interference with daily activities than on the WPAI measure of interference with work, partially because of the smaller sample of people who were employed at both baseline and follow-up.
Th ese results are based on models with only main eff ects. Additional analyses tested for interaction eff ects. Th e interaction between follow-up time and treatment group was not signifi cant for any outcome, although it was nearly signifi cant ( P = 0.088) for CSFBD. Overall, these results indicate that the treatment eff ect seen at 3 months persists at 6 and 12 months, with little decrease.
Several ancillary analyses were conducted in an eff ort to determine which particular GI symptoms were most aff ected by CSM. Table 5 presents the baseline means and change scores of the individual GI symptoms that were included in the IBS symptom score. Th e two CSM groups show a large improvement in abdominal pain / discomfort and in the intestinal gas that persists through 12 months. Th e changes in bloating, constipation, diarrhea, and urgency were greater in CSM than in UC, but were not signifi cantly diff erent in the mixed model test. Table 6 presents the percentage of subjects with at least 50 % improvement in the IBS symptom score and in the abdominal pain / discomfort score, and in odds ratios of CSM-T / IP and Demographics and baseline clinical characteristics are given in Table 3 . Subjects in this sample were mainly female, white, and relatively well educated. Overall, 75 % of them were working, 11 % were retired, 20 % were not working when they enrolled in the study, and 5 % were stay-at-home parents. More than half of those participants who were working gave job titles that were classifi ed as professional. Overall, participants reported having typical IBS symptoms for 10 years (s.d. 14) before their diagnosis: 31 % started in childhood (4 to < 17.99 years), 62 % started between 18 and 49 years of age, and 8 % reported that their Chose not to participate n =255
Received full intervention (7 + sessions) NA n = 55 n= 54
Received partial intervention
Unable to contact n = 4 n =2
Health problems n =2
Received no intervention
Health problems
CONSORT, consolidated standards of reporting trials; CSM-IP, comprehensive self-management-in person; CSM-T / IP, comprehensive self-managementtelephone.
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CSM-IP relative to UC. Th e odds ratios were all large, > 2.3, and almost all were statistically signifi cant. Adverse events include one participant who experienced suicidal thoughts, which led to her withdrawing from the study.
DISCUSSION
Th e results in this trial show that CSM therapy is eff ective, whether delivered primarily by telephone or delivered entirely in person. Both approaches were more eff ective in decreasing GI symptoms and increasing QOL than was UC. Th e magnitude of treatment eff ect was virtually the same for the two delivery modalities. Moreover, these improvements persisted through the 12 months post randomization follow-up (i.e., 9 months post intervention). Th e GI symptoms most strongly aff ected by the intervention were abdominal pain / discomfort and intestinal gas. Th is is interesting in light of an earlier report (38) showing that these two symptoms were most strongly associated with reduced QOL.
Th ere was also a strong eff ect of CSM on cognitive beliefs and work loss and impact on daily activities. Given the large fi nancial impact of IBS because of lost productivity, this fi nding has important implications for potential societal cost savings from CBT (39, 40) . Further research using more extensive measures of productivity loss and health-care costs would be useful in evaluating the cost-eff ectiveness of CSM therapy. It should be noted that the CSM-T / IP delivery mode was not designed to be cheaper to deliver than CSM-IP, in terms of therapist time, as all sessions were ~ 60 min in length, whether delivered by telephone or in person. Th e main benefi t of CSM-T / IP over CSM-IP was the decreased travel time to the therapist ' s offi ce.
Th e CSM intervention is multifaceted, consisting of education and reassurance, nutritional counseling, relaxation strategies, and cognitive restructuring (5) . Although all participants received all components, therapists observed that individuals diff ered with regard to which components they found most helpful. Th e use of a workbook allowed participants to continue using strategies that they found helpful aft er the end of treatment sessions.
One challenge with delivering CSM by telephone became apparent early on in the study: some participants multitasked while on the telephone with their therapist. Th e study protocol was quickly changed so that before the fi rst phone therapy session, the therapist discussed with the participant the importance of being in a quiet place without distractions during the telephone session, and helped the subject to make arrangements for it.
Several studies have shown the effi cacy of CBT delivered in person for IBS (1,5 -7) . Recently, studies have investigated alternative delivery modes for CBT in IBS. An earlier study by our group (5) found a workbook plus one in-person session to be less eff ective overall than eight in-person CBT sessions. Lackner et al. (41) found that 4 CBT sessions in combination with a self-help book were as eff ective as 10 sessions of in-person CBT. Delivery of CBT by trained clinic nurses was also eff ective (8) . Although telephone delivery of psychotherapy has been studied for depression and anxiety (9, 10) , this is the fi rst study of a CBT-based intervention for IBS delivered primarily by telephone.
As in any psychological intervention study, it was not possible to blind subjects as to treatment assignment. It is possible that some of the observed treatment eff ects could be due to the placebo eff ect. However, the fact that treatment diff erences persisted 9 months aft er the end of treatment implies long-term changes in behaviors, habits, attitudes, or beliefs among subjects in the CSM intervention groups. IBS symptom score=diary symptom severity was summarized across all days for each person as the percentage of days on which symptoms were at least moderate. IBSQOL was rated on a 1-to-5 or 1-to-6 Likert scale, e.g., emotional scale ' 1 ' always, ' 2 ' often ' 3 ' sometimes, ' 4 ' seldom, ' 5 ' never. BSI-53 was rated from ' 0 ' not at all, ' 1 ' a little bit, ' 2 ' moderately, ' 3 ' quite a bit and ' 4 ' extremely. CSFBD was rated from ' 1 ' strongly disagree to ' 4 ' neutral to ' 7'strongly agree. WPAI − work loss= WPAI − overall work productivity loss. WPAI − activity = WPAI − daily activity impairment. These items are rated from " 0 " IBS has not effect to " 10 " IBS completely prevents me from working or completely prevented my participation in usual daily activities.
a P value obtained from mixed methods for testing the null hypothesis that the mean is the same in all three treatment groups at all three time points, adjusting for the baseline value of the variable. Symptom severity is reported as the percent of days with moderate or higher severity. Analyses for each symptom were restricted to only those subjects who rate that symptom as moderate or higher severity on at least 10 % of days at baseline. a P value obtained from mixed methods for testing the null hypothesis that the mean is the same in all three treatment groups at all three time points, adjusting for the baseline value of the variable. 
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It should be noted that the CSM-T / IP intervention was not carried out entirely by telephone. Th e fi rst two sessions were in person, to build a therapeutic relationship with the therapist and teach breathing exercises before starting the telephone sessions. Th e fi nal session was also in person, to provide a transition to selfcare. We believe that these three in-person sessions were important to the success of the CSM-T / IP intervention. An intervention that was totally conducted by telephone might not be as eff ective. Anecdotally, the research staff noted that quite a few subjects volunteered a preference for the mode of delivery of CSM, with some having a preference for CSM-T / IP because of reduced travel time, whereas others indicated a preference for CSM-IP because of personal interaction. As this study found both versions to be eff ective, with no evidence that one is better than the other, a fl exible delivery model could be the best approach, with patients allowed a choice in delivery mode for sessions 3 through 8.
In conclusion, this report has shown that the mulitifaceted CSM intervention delivered primarily over the phone by psychiatric nurse practitioners is an eff ective option for treating IBS. Further investigation is warranted into how best to incorporate such an intervention into clinical practice.
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